IP Library Granted Patent US 12,037,366
Granted Patent B2
US 12,037,366 · App. 18/449,904 · Granted Jul 16, 2024

OMPG variants

Inventors: Cynthia Cech (Mountain View, CA); Tim Craig (Mountain View, CA); Christos Tzitzilonis (Mountain View, CA); Alexander Yang (Mountain View, CA); Liv Jensen (Mountain View, CA); Charlotte Yang (Mountain View, CA); Corissa Harris (Mountain View, CA); Matthew Dipietro (Gilroy, CA); Dhruti Dalal (Sunnyvale, CA)
Assignee: Roche Sequencing Solutions, Inc.
C07K14/245C12N9/1252C12Q1/68C12Q1/6874C12Y207/07007G01N33/6803C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,037,366
App. No.
18/449,904
Granted
Jul 16, 2024
Kind
B2
Abstract

The present disclosure provides variant OmpG polypeptides, compositions comprising the OmpG variant polypeptides, and methods for using the variant OmpG polypeptides as nanopores for determining the sequence of single stranded nucleic acids. The variant OmpG nanopores reduce the ionic current noise versus the parental OmpG polypeptide from which they are derived and thereby enable sequencing of polynucleotides with single nucleotide resolution. The reduced ionic current noise also provides for the use of these OmpG nanopore variants in other single molecule sensing applications, e.g., protein sequencing.

Claims (28)

1. A method for sequencing a nucleic acid, the method comprising:

(a) providing a nanopore comprising an OmpG variant, wherein the OmpG variant comprises an amino acid sequence that is at least 95% identical to an amino acid sequence of SEQ ID NO: 2 that has been modified to comprise (i) a deletion of one or more of loop-6 amino acids 216-227, (ii) an E229A amino acid substitution, and (iii) a D215 deletion, wherein the nanopore is disposed within a membrane that is adjacent or in proximity to a sensing electrode;

(b) providing a plurality of tagged nucleotides into a reaction chamber comprising the nanopore, wherein each tagged nucleotide of the tagged nucleotides comprises a tag coupled to a nucleotide, the tag being detectable by the nanopore;

(c) carrying out a polymerization reaction via a polymerase that is coupled to the OmpG variant, thereby incorporating a tagged nucleotide of the tagged nucleotides into a growing nucleotide strand, the growing nucleotide strand being complementary to a single stranded nucleic acid molecule from the nucleic acid sample; and

(d) during the polymerization reaction, detecting, by the nanopore and with the sensing electrode, the tag coupled to the nucleotide that is incorporated into the growing nucleotide strand.

2. The method of claim 1 , wherein the OmpG variant further comprises a mutation of one or more of amino acids R211, E15, R68, Y50, E152, E174, E17, Y259, K114, E174, F66, or E31 of SEQ ID NO:2.

3. The method of claim 2 , wherein the mutation comprises one or more of a R211N, R68N, Y50K, Y50N, or E17K mutation of SEQ ID NO:2.

4. The method of claim 3 , wherein the mutation of SEQ ID NO: 2 is a Y50K amino acid substitution.

5. The method of claim 1 , wherein the OmpG variant further comprises a SpyTag construct.

6. The method of claim 1 , wherein the OmpG variant comprises a deletion corresponding to each of amino acids 216-227 of SEQ ID NO: 2.

7. The method of claim 1 , wherein the polymerase is coupled to the OmpG variant via the SpyTag construct.

8. The method of claim 1 , wherein the OmpG variant nanopore reduces spontaneous gating of the nanopore as compared to a parental OmpG nanopore.

9. The method of claim 1 , wherein the nanopore comprising the OmpG variant has a reduced ionic current noise as compared to a nanopore comprising a parental OmpG.

10. The method of claim 9 , wherein the reduction is a reduction in downward current and upward current.

11. A method for sequencing a nucleic acid, the method comprising:

(a) providing a nanopore comprising an OmpG variant, wherein the OmpG variant comprises an amino acid sequence that is at least 95% identical to an amino acid sequence of SEQ ID NO: 2 that has been modified to comprise (i) a deletion of one or more of loop-6 amino acids 216-227, (ii) an E229A amino acid substitution, and (iii) a Y50K substitution, wherein the nanopore is disposed within a membrane that is adjacent or in proximity to a sensing electrode;

(b) providing a plurality of tagged nucleotides into a reaction chamber comprising the nanopore, wherein each tagged nucleotide of the tagged nucleotides comprises a tag coupled to a nucleotide, the tag being detectable by the nanopore;

(c) carrying out a polymerization reaction via a polymerase that is coupled to the OmpG variant, thereby incorporating a tagged nucleotide of the tagged nucleotides into a growing nucleotide strand, the growing nucleotide strand being complementary to a single stranded nucleic acid molecule from the nucleic acid sample; and

(d) during the polymerization reaction, detecting, by the nanopore and with the sensing electrode, the tag coupled to the nucleotide that is incorporated into the growing nucleotide strand.

12. The method of claim 11 , wherein the OmpG variant further comprises a mutation of one or more of amino acids R211, E15, R68, E152, E174, E17, D215, Y259, K114, E174, F66, or E31 of SEQ ID NO: 2.

13. The method of claim 12 , wherein the mutation comprises one or more of a R211N, R68N, E17K, or D215 mutation of SEQ ID NO:2.

14. The method of claim 12 , wherein the mutation is a D215 deletion.

15. The method of claim 11 , wherein the OmpG variant further comprises a SpyTag construct.

16. The method of claim 11 , wherein the OmpG variant comprises a deletion corresponding to each of amino acids 216-227 of SEQ ID NO: 2.

17. The method of claim 11 , wherein the polymerase is coupled to the OmpG variant via the SpyTag construct.

18. The method of claim 11 , wherein the OmpG variant nanopore reduces spontaneous gating of the nanopore as compared to a parental OmpG nanopore.

19. The method of claim 11 , wherein the nanopore comprising the OmpG variant has a reduced ionic current noise as compared to a nanopore comprising a parental OmpG.

20. The method of claim 19 , wherein the reduction is a reduction in downward current and upward current.

Continuity (5)
Continuation 16925848 · Jul 10, 2020
Continuation 15762092
Provisional Application 62333672 · May 9, 2016
Provisional Application 62222197 · Sep 22, 2015
Related Publication 20240010688A1 · Jan 11, 2024
Cited By (1)
US 12,435,114